Pacmilimab
Pacmilimab (CX-072) is a potent PD-L1 inhibitor. Pacmilimab shows antitumor activity[1].
Product Specifications
CAS Number
[2145091-51-4]
Product Name Alternative
CX-072
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pacmilimab.html
Purity
95.00
Solubility
H2O
Smiles
[Pacmilimab]
Molecular Weight
(152.6 kDa)
References & Citations
[1]Naing A, et al. CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072) : an open-label dose-finding and first-in-human study. J Immunother Cancer. 2021 Jul;9 (7) :e002447.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
138087-ML405 100 µL
LRRC2 (Leucine-rich Repeat-containing Protein 2) (MaxLight 405) discontinued
Sign In for Pricing
View Details MBS7023512-01 0.02 mg
Recombinant Neisseria meningitidis serogroup A / serotype 4A Na(+)-translocating NADH-quinone reductase subunit D (nqrD)
Sign In for Pricing
View Details 
MBS7023512-02 0.1 mg
Recombinant Neisseria meningitidis serogroup A / serotype 4A Na(+)-translocating NADH-quinone reductase subunit D (nqrD)
Sign In for Pricing
View Details